BRIEF-Nektar Therapeutics and Daiichi Sankyo Europe sign European licensing agreement for onzeald experimental treatment for breast cancer and brain metastases
June 01, 2016 at 08:30 AM EDT
June 1 (Reuters) - Nektar Therapeutics Says Also Entitled To Significant Double